No change, our position in ZM has been a bit of a rollercoaster post the pandemic but we now have a new environment as the vaccine is rolled out and competition intensifies. ZM might be ahead of the pack but its still priced for substantial growth with an estimated P/E for 2021 of 150x, were thinking it might be time to take our ~15% profit and walk.
MM is considering selling ZM into current strength
Add To Hit List
